| |
| |
|
| Insider
Information: |
Elicker John E |
| Relationship: |
EVP, Investor Relations |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
70,946 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,160,644 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
70,946 |
|
|
| Total
Value |
$3,160,644 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 0.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, Investor Relations |
2020-03-10 |
70,946 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2012-07-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,675 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,851 |
26,159 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,423 |
42,187 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,169 |
40,764 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-05-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,508 |
35,235 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,471 |
51,061 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,737 |
37,155 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
708 |
48,338 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,043 |
47,630 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,850 |
49,399 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
840 |
50,239 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-05-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,509 |
50,536 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
952 |
50,808 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
60,609 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,360 |
51,827 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,360 |
53,187 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
971 |
60,112 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,043 |
59,141 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,323 |
52,497 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,271 |
52,348 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
496 |
52,286 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2016-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
950 |
53,012 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,043 |
53,715 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
992 |
54,707 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,475 |
57,883 |
0 |
- |
|
74 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
